Pfizer Completes Acquisition of Obesity Drug Developer Metsera

The U.S. pharmaceutical company finalizes the purchase of Metsera, a biotech firm specializing in obesity treatment development.

Summary

No Summary provided as the original text is short

Terms & Concepts
  • Obesity drug: A pharmaceutical treatment designed to aid in weight loss or manage obesity-related health conditions.
  • Acquisition: The act of one company purchasing another company or its assets.
  • Biotech firm: A company that uses biological processes or living organisms to develop medical or agricultural products.